COVID-19 vaccine."Today we concluded talks with the European company CureVac to increase the chances of finding an effective coronavirus vaccine," EU Health Commissioner Stella Kyriakides said.The EU will now begin talks on a contract with CureVac aimed at securing the supply of its potential vaccine for all 27 EU member states should the shot prove safe and effective against COVID-19.German biotechnology firm CureVac has not ruled out a speedy approval process for its prospective vaccine and expects to have it on the market by mid-2021."We are not ruling out accelerated approval, but this can only be achieved in close cooperation with the authorities," CEO Franz-Werner Haas recently told the Boerse Online financial website.CureVac, backed.